124 related articles for article (PubMed ID: 18059140)
1. Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinoma.
Yu GR; Kim SH; Park SH; Cui XD; Xu DY; Yu HC; Cho BH; Yeom YI; Kim SS; Kim SB; Chu IS; Kim DG
Exp Mol Med; 2007 Oct; 39(5):641-52. PubMed ID: 18059140
[TBL] [Abstract][Full Text] [Related]
2. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T
Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748
[TBL] [Abstract][Full Text] [Related]
3. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.
Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL
Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
[TBL] [Abstract][Full Text] [Related]
5. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma.
Xiang ZL; Zeng ZC; Fan J; Tang ZY; Zeng HY; Gao DM
Clin Cancer Res; 2011 Aug; 17(16):5463-72. PubMed ID: 21712445
[TBL] [Abstract][Full Text] [Related]
8. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling.
Nam SW; Park JY; Ramasamy A; Shevade S; Islam A; Long PM; Park CK; Park SE; Kim SY; Lee SH; Park WS; Yoo NJ; Liu ET; Miller LD; Lee JY
Hepatology; 2005 Oct; 42(4):809-18. PubMed ID: 16175600
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357
[TBL] [Abstract][Full Text] [Related]
10. [Determination of expression of eight p53-related genes in hepatocellular carcinoma with tissue microarrays].
Zhu MH; Ni CR; Zhu Z; Li FM; Zhang SM
Ai Zheng; 2003 Jul; 22(7):680-5. PubMed ID: 12866955
[TBL] [Abstract][Full Text] [Related]
11. Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours.
Heringlake S; Hofdmann M; Fiebeler A; Manns MP; Schmiegel W; Tannapfel A
J Hepatol; 2010 Feb; 52(2):220-7. PubMed ID: 20036025
[TBL] [Abstract][Full Text] [Related]
12. Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays.
Shirota Y; Kaneko S; Honda M; Kawai HF; Kobayashi K
Hepatology; 2001 Apr; 33(4):832-40. PubMed ID: 11283847
[TBL] [Abstract][Full Text] [Related]
13. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
Kurokawa Y; Honma K; Takemasa I; Nakamori S; Kita-Matsuo H; Motoori M; Nagano H; Dono K; Ochiya T; Monden M; Kato K
Int J Oncol; 2006 Feb; 28(2):383-91. PubMed ID: 16391793
[TBL] [Abstract][Full Text] [Related]
14. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
15. Discovery of differentially expressed genes related to histological subtype of hepatocellular carcinoma.
Lee D; Choi SW; Kim M; Park JH; Kim M; Kim J; Lee IB
Biotechnol Prog; 2003; 19(3):1011-5. PubMed ID: 12790669
[TBL] [Abstract][Full Text] [Related]
16. HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma.
Wu X; Jia HL; Wang YF; Ren N; Ye QH; Sun HC; Wang L; Liu YK; Tang ZY; Qin LX
Oncogene; 2006 Mar; 25(12):1832-40. PubMed ID: 16261160
[TBL] [Abstract][Full Text] [Related]
17. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
[TBL] [Abstract][Full Text] [Related]
18. Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array.
Okamura Y; Nomoto S; Kanda M; Li Q; Nishikawa Y; Sugimoto H; Kanazumi N; Takeda S; Nakao A
Cancer Lett; 2010 Mar; 289(2):170-7. PubMed ID: 19733004
[TBL] [Abstract][Full Text] [Related]
19. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.
Cheng J; Xie HY; Xu X; Wu J; Wei X; Su R; Zhang W; Lv Z; Zheng S; Zhou L
Cancer Lett; 2011 Nov; 310(1):35-45. PubMed ID: 21763068
[TBL] [Abstract][Full Text] [Related]
20. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma.
Chuma M; Sakamoto M; Yamazaki K; Ohta T; Ohki M; Asaka M; Hirohashi S
Hepatology; 2003 Jan; 37(1):198-207. PubMed ID: 12500205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
